Citius Pharmaceuticals, Inc. - Common Stock (NQ:CTXR)

0.5011 +0.0011 (+0.22%)

Delayed Quote Updated: 4:00 PM EDT, Oct 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Citius Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

This Pharma Company Is Preparing To Launch Its Lead Candidate

July 25, 2024

This Pharma Company Is Preparing To Launch Its Lead Candidate

Via News Direct

Biotech Stocks Race Towards Solutions for Cutaneous T-Cell Lymphoma (CTCL)

July 18, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 18, 2024) - Investorideas.com, a go-to investing platform releases the second...

Via Newsfile

Analysts Hunt for Undervalued Biotech Stocks

July 17, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 17, 2024) - Investorideas.com, a go-to investing platform releases the first...

Via Newsfile

Topics Economy Initial Public Offering

Citius Pharmaceuticals (CTXR) Eyes Breakthrough with Late-Stage Drug Pipeline Poised for Regulatory Approval

July 17, 2024

Via AB Newswire

Bloodstream Infections - From Threats to Solutions

July 11, 2024

Vancouver, Kelowna, and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the second...

Via Newsfile

Topics Death

Citius Pharmaceuticals (CTXR) Nears Key FDA Decisions and Launch Plans for 2024

July 11, 2024

Via AB Newswire

Biopharma Stocks Transformative Innovation for the Future of Health

July 11, 2024

Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. - July 11, 2024) - Investorideas.com, a go-to investing platform releases the first...

Via Newsfile

Topics Artificial Intelligence

Citius Pharma's 'Antibiotic Lock' Effective In Patients With Catheter-Associated Bloodstream Infections ↗

May 21, 2024

Citius Pharmaceuticals' Phase 3 trial results for Mino-Lok, an antibiotic lock solution for central line-associated infections, show significant improvement in time to catheter failure and overall...

Via Benzinga

Yogi Tea Recalls: Yogi Brand Recalls 900,000 Tea Bags for Pesticide Residue ↗

May 21, 2024

Yogi Tea recalls are in effect for some of the company's tea bags over concerns of pesticide residue that may be found in them.

Via InvestorPlace

Topics Product Recall

VFS Stock Alert: VinFast Plunges on NHTSA Probe ↗

May 21, 2024

VinFast Auto stock is down on Tuesday as investors in VFS learn that the company is being investigated over a fatal crash last month.

Via InvestorPlace

Why Is Citius Pharmaceuticals (CTXR) Stock Up 11% Today? ↗

May 21, 2024

Citius Pharmaceuticals stock is up on Tuesday with heavy trading of CTXR shares alongside positive clinical trial results.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

May 21, 2024

Via Benzinga

Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) Featured in Coverage of the EF Hutton Annual Global Conference

May 16, 2024

Via Investor Brand Network

CTXR Stock Earnings: Citius Pharma Meets EPS for Q2 2024 ↗

May 14, 2024

CTXR stock results show that Citius Pharma met analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment

April 18, 2024

Citius Pharmaceuticals (NASDAQ: CTXR) Advances Oncology Asset, Paving Way For Spin Out Of Advanced T-cell Lymphoma Treatment

Via News Direct

Topics Death

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

April 18, 2024

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

April 18, 2024

Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Thursday morning!

Via InvestorPlace

Sidoti Events, LLC’s Virtual November Micro-Cap Conference

November 14, 2023

Via ACCESSWIRE

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 24, 2023

Via Benzinga

Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session ↗

July 31, 2023

Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report.

Via Benzinga

Why Citius Pharmaceuticals Stock Is Plunging Today? ↗

July 31, 2023

The FDA issued a Complete Response Letter regarding Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Biologics License Application (BLA) seeking approval for denileukin diftitox (Lymphir), an engineered...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

July 31, 2023

Via Benzinga

Why China Natural Resources Shares Are Trading Higher By Around 64%; Here Are 20 Stocks Moving Premarket ↗

July 31, 2023

Gainers

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

July 31, 2023

It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!

Via InvestorPlace

CSX, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

July 31, 2023

U.S. stock futures traded mixed this morning on Monday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Combination Therapy for Hemorrhoids: Citius' Combination Products Shows Meaningful Reduction In Symptoms ↗

June 20, 2023

Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido, a topical treatment comprising lidocaine and halobetasol for hemorrhoid relief, significantly reduced symptom severity compared to individual

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

May 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

May 04, 2023

Via Benzinga

Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock? ↗

May 04, 2023

The late-stage biopharma Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is approaching the conclusion of the phase 3 trial for its drug, Mino-Lok.

Via Benzinga

Why Aaron's Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗

April 25, 2023

Gainers ZeroFox Holdings, Inc. (NASDAQ: ZFOX) gained 36.7% to $1.49 in pre-market trading after dropping around 17% on Monday. ZeroFox completed the acquisition of LookingGlass Cyber Solutions, Inc.

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.